Three-Year Safety and Effectiveness of Fixed-Dose Losartan/Hydrochlorothiazide Combination Therapy in Japanese Patients with Hypertension Under Clinical Setting (PALM-1 Extension Study)

By Kita Toshihiro   Yokota Naoto   Ichiki Yoshinari   Ayabe Takao   Etoh Takuma   Tamaki Noboru   Kato Johji   Eto Tanenao   Kitamura Kazuo  

Clinical and Experimental Hypertension, Vol. 34, Iss. 7, 2012-11 ,pp. : 498-503

Informa Healthcare

Access to resources Recommend Favorite

Efficacy and Tolerability of a Combination Tablet of Candesartan Cilexetil and Hydrochlorothiazide in Insufficiently Controlled Primary Hypertension - Comparison with a Combination of Losartan and Hydrochlorothiazide

By ÖHMAN K. PETER   MILON HUGUES   VALNES KOLBJØRN  

Blood Pressure, Vol. 9, Iss. 4, 2000-09 ,pp. : 214-220

Informa Healthcare

Access to resources Recommend Favorite

Candesartan and hydrochlorothiazide in isolated systolic hypertension

By Wing Lindon   Arnolda Leonard   Upton Jane   Molloy Danielle  

Blood Pressure, Vol. 12, Iss. 4, 2003-07 ,pp. : 246-254

Informa Healthcare

Access to resources Recommend Favorite

Nebivolol/Hydrochlorothiazide: A New Fixed-Dose Combination for Effective Simplified Antihypertensive Therapy

By Malacco Ettore  

High Blood Pressure & Cardiovascular Prevention, Vol. 15, Iss. 2, 2008-01 ,pp. : 75-84

Adis International

Access to resources Recommend Favorite

Combination therapy with valsartan/hydrochlorothiazide at doses up to 320/25 mg improves blood pressure levels in patients with hypertension inadequately controlled by valsartan 320 mg monotherapy

By Tuomilehto Jaakko   Tykarski Andrzej   Baumgart Peter   Reimund Bernard   Breton Stephanie Le   Ferber Philippe  

Blood Pressure, Vol. 17, Iss. 1, 2008-06 ,pp. : 15-23

Informa Healthcare

Access to resources Recommend Favorite